… Head of Biomarkers ProQR Therapeutics is a NASDAQ-listed biotechnology company … with an office in and Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease and change lives. A team of 180+ enthusiastic ProQRians from all walks of life and more than 30 different …
… Head of Clinical Quantitative Science ProQR Therapeutics is a NASDAQ-listed biotechnology company … with an office in and Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease and … with statistical software and modeling tools (e.g., R, SAS, Python , Bayesian frameworks). Proven success in …
ProQR will host an investor webcast on May 9, 2024 at 8:00 am EDT with members of the ProQR Management Team to highlight the data being presented in the ASGCT 2024 poster session and will also conduct an analyst Q&A session.
… Analyst & Investor Axiomer® technology R&D Event This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA … guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the …
… be made available in the “Investors & Media” section of ProQR’s website under “ Financial Information ”. The … Do., 30.06.2022 - 13:00 - Do., 30.06.2022 - 14:00 ProQR's 2022 Annual General Meeting (AGM) of Shareholders …
… shares through the Company’s e-mail address legal@proqr.com no later than on May 12, 2021. For more information … The 2021 annual general meeting (AGM) of shareholders of ProQR Therapeutics will take place on Wednesday, May 19, …
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
